Renal function in heart transplant patients after switch to combined mammalian target of rapamycin inhibitor and calcineurin inhibitor therapy
Matthias Helmschrott,1 Rasmus Rivinius,1 Thomas Bruckner,2 Hugo A Katus,1 Andreas O Doesch1 1Department of Cardiology, Angiology, Pneumology, 2Institute for Medical Biometry and Informatics, University of Heidelberg, Heidelberg, Germany Background: A calcineurin inhibitor (CNI)-based immunosuppres...
Main Authors: | Helmschrott M, Rivinius R, Bruckner T, Katus HA, Doesch AO |
---|---|
Format: | Article |
Language: | English |
Published: |
Dove Medical Press
2017-06-01
|
Series: | Drug Design, Development and Therapy |
Subjects: | |
Online Access: | https://www.dovepress.com/renal-function-in-heart-transplant-patients-after-switch-to-combined-m-peer-reviewed-article-DDDT |
Similar Items
-
Proteomic Characterization of Urinary Extracellular Vesicles from Kidney-Transplanted Patients Treated with Calcineurin Inhibitors
by: Laura Carreras-Planella, et al.
Published: (2020-10-01) -
Calcineurin inhibitor induced nephrotoxicity in steroid resistant nephrotic syndrome
by: A Sinha, et al.
Published: (2013-01-01) -
The effect of spironolactone on calcineurin inhibitor induced nephrotoxicity: a multicenter randomized, double-blind, clinical trial (the SPIREN trial)
by: Line Aas Mortensen, et al.
Published: (2018-05-01) -
The Advantages of Polymeric Hydrogels in Calcineurin Inhibitor Delivery
by: Claudia Sandoval-Yañez, et al.
Published: (2020-10-01) -
Impact of initial exposure to calcineurin inhibitors on kidney graft function of patients at high risk to develop delayed graft function
by: L.A. Silva, et al.
Published: (2006-01-01)